Weight loss drug's hidden toll on muscle and bone under the microscope

NCT ID NCT07154719

Ongoing Knowledge-focused Sponsor: Pennington Biomedical Research Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study is looking at what happens to muscle and bone when people lose weight using the drug tirzepatide. Researchers want to see if adding protein shakes and resistance exercise can protect muscle and bone. The study will enroll 50 adults with obesity and track changes over 6 months using scans and blood tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tirzepatide (a GLP-1 based drug for weight loss) plus a lifestyle toolkit of protein shakes and resistance exercise
What this could lead to: If successful, this could help doctors understand how to preserve muscle and bone health during weight loss with GLP-1 drugs.
What could go wrong: This is a small, early-phase study focused on measuring changes, not on proving a treatment works. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG EFFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Musculoskeletal Abnormalities Obesity obesity disorder osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG EFFECT MUSCULOSKELETAL ABNORMALITIES OBESITY OSTEOPOROSIS SARCOPENIC OBESITY

Contacts and locations

Locations

MaineHealth Center for Clinical and Translational Science

Scarborough, Maine, 04074, United States
Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.